Search results for

A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam – who received the world’s first recorded patent in 1449 diary@managingip.com

A Court of Appeal ruling last week against Dyson was another missed opportunity for registered designs in Britain, say lawyers

Four leaders in IP received recognition for outstanding achievement in the industry at Managing IP's Global and North American awards last month. At the Global Awards, held in London, Peter Messerli and Jiang Zhipei were the recipients. Messerli (left) was congratulated for his years of service at the EPO, with three terms as president of the Boards of Appeal, and the work there that has developed the law on several important issues. Jiang Zhipei is the former chief justice of the Intellectual Property Chamber of the Supreme People's Court of China and was congratulated for his work at the court as well as innovation in spreading the word of IP in China.

The USPTO's Trademark Trial and Appeal Board (TTAB) has published the long-awaited third edition of its Trademark Board Manual of Procedure (TBMP), to the delight of US trade mark owners and practitioners.

A judgment by the UK High Court has built on two previous cases to confirm when a defence against trade mark infringement based on honest practice applies

The luxury brand Tory Burch secured a $164 million judgment in the Southern District of New York last week – believed to be the largest damages award issued in an online counterfeiting case in the fashion industry

With the likelihood that licensing in Europe may change, Hester Heringa questions whether the present European legislation is satisfactory and looks at what changes can be expected

With rulings against Pirate Bay and legislative reform in various jurisdictions, the role of ISPs is evolving fast. Five local lawyers explain current practice and make predictions for the future

Austria

The Court of Justice of the EU is to clarify whether supplementary protection certificates (SPCs) can be obtained for second medical use patents